Short Interest in Upexi, Inc. (NASDAQ:UPXI) Drops By 43.9%

Upexi, Inc. (NASDAQ:UPXI) saw a significant decline in short interest during the month of February. As of February 28th, there was short interest totalling 20,800 shares, a decline of 43.9% from the February 13th total of 37,100 shares. Based on an average trading volume of 142,000 shares, the short-interest ratio is presently 0.1 days. Approximately 2.0% of the shares of the stock are short sold.

Upexi Price Performance

NASDAQ UPXI opened at $2.52 on Friday. The stock’s 50 day simple moving average is $3.50 and its 200 day simple moving average is $4.12. Upexi has a one year low of $2.17 and a one year high of $15.91. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.53 and a current ratio of 0.58.

Upexi (NASDAQ:UPXI) last posted its quarterly earnings data on Friday, February 14th. The company reported ($1.24) EPS for the quarter. The business had revenue of $4.01 million during the quarter.

Institutional Investors Weigh In On Upexi

A hedge fund recently bought a new stake in Upexi stock. Bank of Montreal Can purchased a new stake in shares of Upexi, Inc. (NASDAQ:UPXI) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,008 shares of the company’s stock, valued at approximately $36,000. Bank of Montreal Can owned about 0.81% of Upexi at the end of the most recent reporting period. 5.68% of the stock is owned by institutional investors and hedge funds.

About Upexi

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.